Argos Therapeutics' immunotherapy technology receives US & EU patents pharmabiz.com These candidates include AGS-003 to treat metastatic renal cell carcinoma, AGS-004 to treat HIV, AGS-009 to treat lupus, and AGS-010 to treat transplant rejection and autoimmune disease.” US Patent 8,221,981 is entitled “Primers and probes for the ... |
